APPLICATION
ANDA219989
TYPE
ANDA
DOSAGE FORM
CAPSULE, EXTENDED RELEASE
MARKETING STATUS
None (Tentative Approval)
Products
CARBIDOPA AND LEVODOPANone (Tentative Approval)
CARBIDOPA, LEVODOPA 52.5MG · CAPSULE, EXTENDED RELEASE
CARBIDOPA AND LEVODOPANone (Tentative Approval)
CARBIDOPA, LEVODOPA 70MG · CAPSULE, EXTENDED RELEASE
CARBIDOPA AND LEVODOPANone (Tentative Approval)
CARBIDOPA, LEVODOPA 87.5MG · CAPSULE, EXTENDED RELEASE
CARBIDOPA AND LEVODOPANone (Tentative Approval)
CARBIDOPA, LEVODOPA 210MG · CAPSULE, EXTENDED RELEASE
CARBIDOPA AND LEVODOPANone (Tentative Approval)
CARBIDOPA, LEVODOPA 280MG · CAPSULE, EXTENDED RELEASE
CARBIDOPA AND LEVODOPANone (Tentative Approval)
CARBIDOPA, LEVODOPA 350MG · CAPSULE, EXTENDED RELEASE
CARBIDOPA AND LEVODOPANone (Tentative Approval)
CARBIDOPA, LEVODOPA 140MG · CAPSULE, EXTENDED RELEASE
Approval history
2025-11-12UNKNOWN · Original · standardTA
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.